Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.5~1ug/kg/min remifentanil combined with 0.2~0.5mg/kg/h esketamine for the physiological testing phase of DBS surgery.[2] Esketamine,
Remifentanil (Remifentanilo)
[4] Remifentanil hydrochloride (Remifentanil hydrochloride),
Esketamine ,
Remifentanil (Remifentanil),
Esketamine hydrochloride 💬
[6] GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
OPRM1 💬
[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Estrogen signaling pathway, Glutamatergic synapse, Hormone signaling, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 6 💬
2Remifentanil[1] Remifentanil (Remifentanilo)[2] Remifentanil hydrochloride (Remifentanil hydrochloride),
Remifentanil (Remifentanil) 💬
[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[4] 6, 22, 70, 96 💬